Literature DB >> 9039702

Tryptophan-N-formylated gramicidin causes growth inhibition of Plasmodium falciparum by inducing potassium efflux from infected erythrocytes.

M A Otten-Kuipers1, G W Coppens-Burkunk, N A Kronenburg, M de A Vis, B Roelofsen, J A Op den Kamp.   

Abstract

In a study of the supposed selective action of tryptophan-N-formylated gramicidin (NFG) on infected erythrocytes as well as the relationship between the ability of NFG to inhibit parasite growth and its capacity to induce potassium leakage from infected cells, a series of experiments was performed in which in vitro cultures of Plasmodium falciparum were incubated with NFG or gramicidin. Those cultures were subsequently assayed for intracellular sodium and potassium contents, cell lysis, and/or parasite viability. It is shown and discussed that although NFG can attack both infected and uninfected erythrocytes, resulting in potassium efflux from and sodium influx into these cells, the effects are much greater on infected erythrocytes than on uninfected ones. Furthermore, the results strongly suggest that NFG-mediated potassium efflux is the direct cause of parasite death.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9039702     DOI: 10.1007/s004360050230

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  3 in total

1.  Effect of tryptophan-N-formylated gramicidin on growth of Plasmodium berghei in mice.

Authors:  M A Otten-Kuipers; F F Franssen; H Nieuwenhuijs; J P Overdulve; B Roelofsen; J A Op den Kamp
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  Screening for potential prophylactics targeting sporozoite motility through the skin.

Authors:  Ross G Douglas; Miriam Reinig; Matthew Neale; Friedrich Frischknecht
Journal:  Malar J       Date:  2018-08-31       Impact factor: 2.979

3.  Antiplasmodial Cyclodecapeptides from Tyrothricin Share a Target with Chloroquine.

Authors:  Adrienne N-N Leussa; Marina Rautenbach
Journal:  Antibiotics (Basel)       Date:  2022-06-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.